Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svane

Showing results (311-320 of 811) with videos related to

Pageof 82
Sort By:
Lancet (London, England)|March 30, 1996
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patientsC G Ericsson, A Hamsten, J Nilsson, et al.
Cardiovascular Drugs and Therapy|May 1, 1997
Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trialsU de Faire, C G Ericsson, L Grip, et al.
Human Immunology|May 20, 2008
Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patientsPia Kvistborg, Sine Reker Hadrup, Inge Marie Svane, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 1, 1996
Methylcholanthrene-induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expressionA M Engel, I M Svane, S Mouritsen, et al.
Journal for Immunotherapy of Cancer|August 5, 2020
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanomaTroels Holz Borch, Rikke Andersen, Eva Ellebaek, et al.
Cancers|September 14, 2024
Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and BinimetinibSidsel Pedersen, Marc Østergaard Nielsen, Marco Donia, et al.
Ugeskrift for Laeger|October 16, 2019
[Chimeric antigen receptor T-cell therapy]Klaus Müller, Marianne Ifversen, Katrine Kielsen, et al.
Scandinavian Journal of Immunology|January 6, 2011
Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2J Bjoern, M K Brimnes, M H Andersen, et al.
Diabetes & Vascular Disease Research|April 7, 2010
Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty studyCamilla Hage, Anna Norhammar, Lars Grip, et al.
Expert Opinion on Emerging Drugs|December 9, 2016
Emerging drugs for the treatment of obesityChristoffer Martinussen, Kirstine Nyvold Bojsen-Moller, Maria Saur Svane, et al.
Pageof 82

Showing results (311-320 of 811) with videos related to

Sort By:
Pageof 82
Lancet (London, England)|March 30, 1996
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patientsC G Ericsson, A Hamsten, J Nilsson, et al.
Cardiovascular Drugs and Therapy|May 1, 1997
Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trialsU de Faire, C G Ericsson, L Grip, et al.
Human Immunology|May 20, 2008
Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patientsPia Kvistborg, Sine Reker Hadrup, Inge Marie Svane, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 1, 1996
Methylcholanthrene-induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expressionA M Engel, I M Svane, S Mouritsen, et al.
Journal for Immunotherapy of Cancer|August 5, 2020
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanomaTroels Holz Borch, Rikke Andersen, Eva Ellebaek, et al.
Cancers|September 14, 2024
Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and BinimetinibSidsel Pedersen, Marc Østergaard Nielsen, Marco Donia, et al.
Ugeskrift for Laeger|October 16, 2019
[Chimeric antigen receptor T-cell therapy]Klaus Müller, Marianne Ifversen, Katrine Kielsen, et al.
Scandinavian Journal of Immunology|January 6, 2011
Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2J Bjoern, M K Brimnes, M H Andersen, et al.
Diabetes & Vascular Disease Research|April 7, 2010
Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty studyCamilla Hage, Anna Norhammar, Lars Grip, et al.
Expert Opinion on Emerging Drugs|December 9, 2016
Emerging drugs for the treatment of obesityChristoffer Martinussen, Kirstine Nyvold Bojsen-Moller, Maria Saur Svane, et al.
Pageof 82